TRIANGLE GROUP PRACTICE
2 MORLEY ROAD, LEWISHAM, LONDON
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 39 | 47 | 83.0% | |
| CKD 4 | 2008 | 32 | 40 | 80.0% | |
| CKD 5 | 2009 | 18 | 20 | 90.0% | |
| CKD 5 | 2010 | 13 | 14 | 92.9% | |
| CKD 5 | 2011 | 16 | 19 | 84.2% | |
| CKD 5 | 2012 | 25 | 28 | 89.3% | |
| CKD 5 | 2013 | 25 | 31 | 80.6% | |
| CKD003 | 2014 | 25 | 29 | 86.2% | |
| CKD003 | 2015 | 25 | 30 | 83.3% | |
| NM84 | 2016 | 21 | 29 | 72.4% | |
| NM84 | 2017 | 20 | 29 | 69.0% | |
| NM84 | 2018 | 17 | 28 | 60.7% | |
| NM84 | 2019 | 17 | 27 | 63.0% | |
| NM84 | 2020 | 16 | 26 | 61.5% | |
| NM84 | 2022 | 15 | 23 | 65.2% | |
| NM84 | 2023 | 18 | 26 | 69.2% |
